FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024241872> ?p ?o ?g. }

• W2024241872 endingPage "83" @default.
• W2024241872 startingPage "75" @default.
• W2024241872 abstract "The development of antibodies to asparaginase may attenuate the pharmacologic effect of asparaginase treatment, may be associated with hypersensitivity reactions, and may necessitate switching to a different commercial asparaginase preparation for current or future therapy. Thus, development of an ELISA for measurement of anti-asparaginase antibody levels is important in the clinical setting. An anti-asparaginase antibody reference was established by screening 65 plasma samples from six patients with acute lymphoblastic leukemia (ALL) who had recently developed a hypersensitivity reaction to Escherichia coli or Erwinia chrysanthemi asparaginase therapy. Twenty-one plasma samples were selected for the anti-asparaginase antibody reference pool. Five micrograms per milliliter of commercial E. coli and Erwinia asparaginase and 10 microg/ml of E. coli asparaginase conjugated with polyethylene glycol (PEG asparaginase) were found to be optimal as coating antigen concentrations. Anti-asparaginase antibody concentrations were determined using a commercial polyclonal goat anti-human IgG horseradish peroxidase conjugate. The antibody reference curves were linear in a range of absorbance from 0.1 to 1. 5 O.D. units for dilutions from 1:1600 to 1:51,200. Inter-assay coefficients of variation were 9.04, 14.7 and 13.0%, and intra-assay coefficients of variation were 1.44, 4.43 and 3.28% for antibodies against E. coli, Erwinia, and PEG L-asparaginase, respectively. The cut-off for positivity in plasma was determined as mean+2 S.D. of the optical density values for plasma from untreated healthy volunteers. Measurement of specific IgG by this ELISA allows for the evaluation of plasma anti-asparaginase antibody concentrations in patients receiving one or more of the multiple commercial L-asparaginase preparations." @default.
• W2024241872 created "2016-06-24" @default.
• W2024241872 creator A5002125313 @default.
• W2024241872 creator A5009866488 @default.
• W2024241872 creator A5011496181 @default.
• W2024241872 creator A5011962563 @default.
• W2024241872 creator A5018363328 @default.
• W2024241872 creator A5029099297 @default.
• W2024241872 date "2000-05-01" @default.
• W2024241872 modified "2023-10-16" @default.
• W2024241872 title "ELISA to evaluate plasma anti-asparaginase IgG concentrations in patients with acute lymphoblastic leukemia" @default.
• W2024241872 cites W1887863677 @default.
• W2024241872 cites W1940732706 @default.
• W2024241872 cites W1965769627 @default.
• W2024241872 cites W1970593462 @default.
• W2024241872 cites W1995905554 @default.
• W2024241872 cites W2040730344 @default.
• W2024241872 cites W2049552282 @default.
• W2024241872 cites W2053132594 @default.
• W2024241872 cites W2131669897 @default.
• W2024241872 cites W2133750402 @default.
• W2024241872 cites W2136056069 @default.
• W2024241872 cites W2146519771 @default.
• W2024241872 cites W4253830259 @default.
• W2024241872 doi "https://doi.org/10.1016/s0022-1759(00)00182-4" @default.
• W2024241872 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10821949" @default.
• W2024241872 hasPublicationYear "2000" @default.
• W2024241872 type Work @default.
• W2024241872 sameAs 2024241872 @default.
• W2024241872 citedByCount "25" @default.
• W2024241872 countsByYear W20242418722012 @default.
• W2024241872 countsByYear W20242418722014 @default.
• W2024241872 countsByYear W20242418722015 @default.
• W2024241872 countsByYear W20242418722016 @default.
• W2024241872 countsByYear W20242418722017 @default.
• W2024241872 countsByYear W20242418722018 @default.
• W2024241872 countsByYear W20242418722019 @default.
• W2024241872 countsByYear W20242418722022 @default.
• W2024241872 countsByYear W20242418722023 @default.
• W2024241872 crossrefType "journal-article" @default.
• W2024241872 hasAuthorship W2024241872A5002125313 @default.
• W2024241872 hasAuthorship W2024241872A5009866488 @default.
• W2024241872 hasAuthorship W2024241872A5011496181 @default.
• W2024241872 hasAuthorship W2024241872A5011962563 @default.
• W2024241872 hasAuthorship W2024241872A5018363328 @default.
• W2024241872 hasAuthorship W2024241872A5029099297 @default.
• W2024241872 hasConcept C10138342 @default.
• W2024241872 hasConcept C134306372 @default.
• W2024241872 hasConcept C153911025 @default.
• W2024241872 hasConcept C159654299 @default.
• W2024241872 hasConcept C162324750 @default.
• W2024241872 hasConcept C181199279 @default.
• W2024241872 hasConcept C185592680 @default.
• W2024241872 hasConcept C197336794 @default.
• W2024241872 hasConcept C203014093 @default.
• W2024241872 hasConcept C2776964284 @default.
• W2024241872 hasConcept C2777676563 @default.
• W2024241872 hasConcept C2778461978 @default.
• W2024241872 hasConcept C2778904437 @default.
• W2024241872 hasConcept C2909962599 @default.
• W2024241872 hasConcept C33923547 @default.
• W2024241872 hasConcept C54400483 @default.
• W2024241872 hasConcept C55493867 @default.
• W2024241872 hasConcept C71924100 @default.
• W2024241872 hasConcept C86803240 @default.
• W2024241872 hasConcept C956191 @default.
• W2024241872 hasConceptScore W2024241872C10138342 @default.
• W2024241872 hasConceptScore W2024241872C134306372 @default.
• W2024241872 hasConceptScore W2024241872C153911025 @default.
• W2024241872 hasConceptScore W2024241872C159654299 @default.
• W2024241872 hasConceptScore W2024241872C162324750 @default.
• W2024241872 hasConceptScore W2024241872C181199279 @default.
• W2024241872 hasConceptScore W2024241872C185592680 @default.
• W2024241872 hasConceptScore W2024241872C197336794 @default.
• W2024241872 hasConceptScore W2024241872C203014093 @default.
• W2024241872 hasConceptScore W2024241872C2776964284 @default.
• W2024241872 hasConceptScore W2024241872C2777676563 @default.
• W2024241872 hasConceptScore W2024241872C2778461978 @default.
• W2024241872 hasConceptScore W2024241872C2778904437 @default.
• W2024241872 hasConceptScore W2024241872C2909962599 @default.
• W2024241872 hasConceptScore W2024241872C33923547 @default.
• W2024241872 hasConceptScore W2024241872C54400483 @default.
• W2024241872 hasConceptScore W2024241872C55493867 @default.
• W2024241872 hasConceptScore W2024241872C71924100 @default.
• W2024241872 hasConceptScore W2024241872C86803240 @default.
• W2024241872 hasConceptScore W2024241872C956191 @default.
• W2024241872 hasIssue "1-2" @default.
• W2024241872 hasLocation W20242418721 @default.
• W2024241872 hasLocation W20242418722 @default.
• W2024241872 hasOpenAccess W2024241872 @default.
• W2024241872 hasPrimaryLocation W20242418721 @default.
• W2024241872 hasRelatedWork W1966490926 @default.
• W2024241872 hasRelatedWork W2037651561 @default.
• W2024241872 hasRelatedWork W2119261566 @default.
• W2024241872 hasRelatedWork W2313903280 @default.
• W2024241872 hasRelatedWork W2322734595 @default.
• W2024241872 hasRelatedWork W2356915299 @default.
• W2024241872 hasRelatedWork W2380792224 @default.

• next